Product Information
TERBINAFINE HCL 250 MG TABLET is a generic product labeled by Chartwell RX LLC, priced at $0.1341 per EA under NDC 62135057230. Its NADAC has been published 213 times since Jun 1, 2022.
Strength
250 mg/1
Manufacturer
Chartwell RX LLCNDC
62135057230
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
TERBINAFINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA078199On Market Since
7/2/2007
Pharmacological Classes
Price Statistics
The NADAC for TERBINAFINE HCL 250 MG TABLET has been published 213 times since Jun 1, 2022, and over the history we have for it it has declined 15.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1341 per EA |
|---|---|
| All-time high | $0.1683 (Nov 16, 2022) |
| All-time low | $0.1158 (Nov 20, 2024) |
| 52-week high | $0.1513 |
| 52-week low | $0.1341 |
| Median price | $0.1510 |
| Average price | $0.1495 |
| Largest weekly change | -21.1% (Nov 20, 2024) |
| Weeks tracked | 213 |
| Tracking since | Jun 1, 2022 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of TERBINAFINE HCL 250 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for TERBINAFINE HCL 250 MG TABLET, manufactured by Chartwell RX LLC, is $0.1341 per EA (NDC 62135057230), effective Jun 24, 2026.
How has the price of TERBINAFINE HCL 250 MG TABLET changed over time?
Over the history we have for it, the NADAC for TERBINAFINE HCL 250 MG TABLET has declined 15.5%. It has been tracked across 213 weekly CMS publications since Jun 1, 2022.
What are the highest and lowest recorded NADAC prices for TERBINAFINE HCL 250 MG TABLET?
Since Jun 1, 2022, the NADAC for TERBINAFINE HCL 250 MG TABLET has ranged from a low of $0.1158 (Nov 20, 2024) to a high of $0.1683 (Nov 16, 2022), with a median of $0.1510 per EA.
Are there cheaper alternatives to TERBINAFINE HCL 250 MG TABLET?
3 NADAC-published products share the same active ingredient, strength, and dosage form as TERBINAFINE HCL 250 MG TABLET, but none are currently priced below it.
Who manufactures TERBINAFINE HCL 250 MG TABLET?
TERBINAFINE HCL 250 MG TABLET (NDC 62135057230) is labeled by Chartwell RX LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification